Combined anticancer therapy with imidazoacridinone analogue C‐1305 and paclitaxel in human lung and colon cancer xenografts—Modulation of tumour angiogenesis

The acridanone derivative 5‐dimethylaminopropylamino‐8‐hydroxytriazoloacridinone (C‐1305) has been described as a potent inhibitor of cancer cell growth. Its mechanism of action in in vitro conditions was attributed, among others, to its ability to bind and stabilize the microtubule network and subs...

Descripción completa

Detalles Bibliográficos
Autores principales: Świtalska, Marta, Filip‐Psurska, Beata, Milczarek, Magdalena, Psurski, Mateusz, Moszyńska, Adrianna, Dąbrowska, Aleksandra M., Gawrońska, Małgorzata, Krzymiński, Karol, Bagiński, Maciej, Bartoszewski, Rafał, Wietrzyk, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279600/
https://www.ncbi.nlm.nih.gov/pubmed/35701366
http://dx.doi.org/10.1111/jcmm.17430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279600/
https://www.ncbi.nlm.nih.gov/pubmed/35701366
http://dx.doi.org/10.1111/jcmm.17430

Ejemplares similares